会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Topical formulations comprising 1-N-arylpyrazole derivatives and amitraz
    • 包含1-N-芳基吡唑衍生物和氨基拉唑的局部制剂
    • US07531186B2
    • 2009-05-12
    • US10783459
    • 2004-02-20
    • Albert BoeckhLuiz Gustavo CramerMark D. Soll
    • Albert BoeckhLuiz Gustavo CramerMark D. Soll
    • A01N25/32
    • A01N43/56A01N47/02A01N2300/00A01N37/52
    • The present invention provides for, inter alia, novel topical formulations comprising at least one 1-N-arypyrazole derivative and amitraz and to methods for treating, controlling, or preventing parasite infestations on mammals or birds The inventive formulations include spot-on, pour-on or spray formulations and may include a further ectoparasiticide, such as an IGR compound, an avermectin or milbemycin derivative, or a pyrethroid insecticides, and anthelmintics, such as benzimidazoles and imidazothiazoles. The inventive formulation provides a larger duration of parasite control at a faster rate of control. The inventive formula remains effective up to three months from the first application. Moreover, the inventive formulations prevent tick attachment to the animal, thereby providing protection against tick borne diseases. The ectoparasites which may be controlled, treated or prevented by the present invention includes ticks, fleas, mites, mange, lice, mosquitoes, flies and cattle grubs.
    • 本发明特别提供了包含至少一种1-N-阿吡唑衍生物和氨喋啶的新型局部制剂,以及用于治疗,控制或预防哺乳动物或鸟类寄生虫侵袭的方法。本发明的制剂包括点状, 可以包括另外的外寄生物杀虫剂,例如IGR化合物,除虫菌素或米尔倍霉素衍生物,拟除虫菊酯杀虫剂,以及驱肠虫药如苯并咪唑和咪唑并噻唑。 本发明的配方以更快的控制速率提供更大的寄生虫控制持续时间。 本发明的公式从第一次申请至多三个月仍然有效。 此外,本发明的制剂防止蜱附着于动物,从而提供防止蜱携带疾病的保护。 本发明可以控制,治疗或预防的外寄生虫包括蜱,跳蚤,螨虫,虱子,虱子,蚊子,苍蝇和牛。。。
    • 7. 发明授权
    • Topical formulations comprising 1-N-arylpyrazole derivatives and amitraz
    • 包含1-N-芳基吡唑衍生物和氨基拉唑的局部制剂
    • US08242161B2
    • 2012-08-14
    • US12420325
    • 2009-04-08
    • Albert BoeckhLuiz Gustavo CramerMark D. Soll
    • Albert BoeckhLuiz Gustavo CramerMark D. Soll
    • A01N43/56
    • A01N43/56A01N47/02A01N2300/00A01N37/52
    • The present invention provides for, inter alia, novel topical formulations comprising at least one 1-N-arypyrazole derivative and amitraz and to methods for treating, controlling, or preventing parasite infestations on mammals or birds The inventive formulations include spot-on, pour-on or spray formulations and may include a further ectoparasiticide, such as an IGR compound, an avermectin or milbemycin derivative, or a pyrethroid insecticides, and anthelmintics, such as benzimidazoles and imidazothiazoles. The inventive formulation provides a larger duration of parasite control at a faster rate of control. The inventive formula remains effective up to three months from the first application. Moreover, the inventive formulations prevent tick attachment to the animal, thereby providing protection against tick borne diseases. The ectoparasites which may be controlled, treated or prevented by the present invention includes ticks, fleas, mites, mange, lice, mosquitoes, flies and cattle grubs.
    • 本发明特别提供了包含至少一种1-N-阿吡唑衍生物和氨喋啶的新型局部制剂,以及用于治疗,控制或预防哺乳动物或鸟类寄生虫侵袭的方法。本发明的制剂包括点状, 可以包括另外的外寄生物杀虫剂,例如IGR化合物,除虫菌素或米尔倍霉素衍生物,拟除虫菊酯杀虫剂,以及驱肠虫药如苯并咪唑和咪唑并噻唑。 本发明的配方以更快的控制速率提供更大的寄生虫控制持续时间。 本发明的公式从第一次申请至多三个月仍然有效。 此外,本发明的制剂防止蜱附着于动物,从而提供防止蜱携带疾病的保护。 本发明可以控制,治疗或预防的外寄生虫包括蜱,跳蚤,螨虫,虱子,虱子,蚊子,苍蝇和牛。。。
    • 8. 发明申请
    • Topical Formulations Comprising 1-N-Arylpyrazole Derivatives and Amitraz
    • 包含1-N-Arylpyrazole衍生物和Amitraz的局部制剂
    • US20090192207A1
    • 2009-07-30
    • US12420325
    • 2009-04-08
    • Albert BoeckhLuiz Gustavo CramerMark D. Soll
    • Albert BoeckhLuiz Gustavo CramerMark D. Soll
    • A01N43/56
    • A01N43/56A01N47/02A01N2300/00A01N37/52
    • The present invention provides for, inter alia, novel topical formulations comprising at least one 1-N-arypyrazole derivative and amitraz and to methods for treating, controlling, or preventing parasite infestations on mammals or birds The inventive formulations include spot-on, pour-on or spray formulations and may include a further ectoparasiticide, such as an IGR compound, an avermectin or milbemycin derivative, or a pyrethroid insecticides, and anthelmintics, such as benzimidazoles and imidazothiazoles. The inventive formulation provides a larger duration of parasite control at a faster rate of control. The inventive formula remains effective up to three months from the first application. Moreover, the inventive formulations prevent tick attachment to the animal, thereby providing protection against tick borne diseases. The ectoparasites which may be controlled, treated or prevented by the present invention includes ticks, fleas, mites, mange, lice, mosquitoes, flies and cattle grubs.
    • 本发明特别提供了包含至少一种1-N-阿吡唑衍生物和氨喋啶的新型局部制剂,以及用于治疗,控制或预防哺乳动物或鸟类寄生虫侵袭的方法。本发明的制剂包括点状, 可以包括另外的外寄生物杀虫剂,例如IGR化合物,除虫菌素或米尔倍霉素衍生物,拟除虫菊酯杀虫剂,以及驱肠虫药如苯并咪唑和咪唑并噻唑。 本发明的配方以更快的控制速率提供更大的寄生虫控制持续时间。 本发明的公式从第一次申请至多三个月仍然有效。 此外,本发明的制剂防止蜱附着于动物,从而提供防止蜱携带疾病的保护。 本发明可以控制,治疗或预防的外寄生虫包括蜱,跳蚤,螨虫,虱子,虱子,蚊子,苍蝇和牛。。。